These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6202064)

  • 1. [Protease inhibitors in the complex treatment of rheumatoid arthritis].
    Parashchak AP; Man'ko VI; Mazepa MA; Vatseba NS; Shvedenko LA
    Vrach Delo; 1984 Mar; (3):66-8. PubMed ID: 6202064
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the kinin system enzymes and a justification for the use of proteolysis inhibitors in rheumatoid polyarthritis].
    Veremeenko KN; Skliarenko ET
    Vrach Delo; 1973 Jul; 7(7):31-4. PubMed ID: 4356927
    [No Abstract]   [Full Text] [Related]  

  • 3. [What can we expect from therapy with enzyme inhibitors in rheumatology].
    Riffat GV
    Therapeutique; 1971 Oct; 47(8):729-32. PubMed ID: 5002038
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis.
    Khan S
    Med Hypotheses; 2008 Nov; 71(5):818. PubMed ID: 18650027
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of kontrikal on kinin dynamics in rheumatoid arthritis].
    Bersudskaia SL; Gudilina VG
    Vopr Revm; 1979; (2):40-2. PubMed ID: 380158
    [No Abstract]   [Full Text] [Related]  

  • 6. [Critical considerations on the effects of a protease inhibitor].
    Ambanelli U; Ferraccioli GF; Maini M
    Rev Esp Reum Enferm Osteoartic; 1976; 19(2):181-201. PubMed ID: 1085459
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kallikrein-protease inhibitors (contrical, gordox) in the complex treatment of patients with myocardial infarction].
    Leshchinskiĭ LA; Pimenov LT; Sudneva LI
    Sov Med; 1983; (4):61-5. PubMed ID: 6191397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of arthrogenic contractures in rheumatoid arthritis patients with trasylol].
    Mikhalevich PF
    Klin Med (Mosk); 1972 Aug; 50(8):110-2. PubMed ID: 4540804
    [No Abstract]   [Full Text] [Related]  

  • 9. [The status of various indicators of the protease inhibitor system in blood and synovial fluid in rheumatoid arthritis].
    Danilova TG; Platonova LV; Paskhina TS
    Vopr Med Khim; 1993; 39(3):40-3. PubMed ID: 8101408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of trasylol as an inhibitor of proteases of the fibrinolysis system during extracorporeal circulation].
    Masiak M; Bross W
    Folia Med Cracov; 1980; 22(3-4):455-61. PubMed ID: 6169610
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complications in the use of proteinase inhibitors].
    Gostishchev VK; Tolstykh PI; Alikhanov VP
    Vestn Khir Im I I Grek; 1975 Apr; 114(4):63-6. PubMed ID: 1083582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of complications following vascular arterial surgery with a protease inhibitor].
    Skóra K; Popielska-Greblicka H; Samplawska-Maj B; Szyber P; Szydlowski Z; Witkiewicz W
    Pol Tyg Lek; 1974 Jan; 29(2):45-8. PubMed ID: 4544924
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intra-articular use of a proteinase inhibitor in gonarthrosis and microcrystalline arthropathies].
    Salvini S; Scarpati B
    Clin Ter; 1974 Jul; 70(1):63-7. PubMed ID: 4547051
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detoxication and antiproteolytic therapy of radiation complications].
    Iakhontov NE; Klimov IA; Lavrikova LP; Martynov AD; Provorova TP
    Med Radiol (Mosk); 1984 Nov; 29(11):76-7. PubMed ID: 6209523
    [No Abstract]   [Full Text] [Related]  

  • 15. An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis.
    Lazarus DD; Doyle EG; Bernier SG; Rogers AB; Labenski MT; Wakefield JD; Karp RM; Clark EJ; Lorusso J; Hoyt JG; Thompson CD; Hannig G; Westlin WF
    Inflamm Res; 2008 Jan; 57(1):18-27. PubMed ID: 18209961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical basis for using proteolysis inhibitors in inflammatory processes of the cornea].
    Chesnokova NB; Kasavina BS; Shchipanova AI
    Vestn Oftalmol; 1983; (1):48-50. PubMed ID: 6187116
    [No Abstract]   [Full Text] [Related]  

  • 17. Protease inhibitors in the treatment of hereditary angioedema.
    Ritchie BC
    Transfus Apher Sci; 2003 Dec; 29(3):259-67. PubMed ID: 14572819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibition as a novel therapy in treating rheumatoid arthritis.
    Brun J
    Med Hypotheses; 2008; 71(1):65-72. PubMed ID: 18424014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The action of protease inhibitors in acute myocardial infarct].
    Palmieri M
    Minerva Cardioangiol; 1967 Jul; 15(7):481-3. PubMed ID: 5303823
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitors of proteolysis in the complex therapy of allergic lesions of the oral mucosa].
    Danilevskiĭ NF; Zavernaia AM; Khomenko LA
    Stomatologiia (Mosk); 1977; 56(1):30-2. PubMed ID: 300193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.